Stockscreener 앱 받기
0.005
46.83%
-0.0155
시간 외 거래:
.01
0.005
+100.00%
Ocean Biomedical Inc 주식(OCEA)의 최신 뉴스
Ocean Biomedical Faces Imminent Nasdaq Delisting - TipRanks
Delisting of Securities from The Nasdaq Stock Market - The Globe and Mail
Ocean Biomedical to be delisted from Nasdaq following appeal denial By Investing.com - Investing.com India
Ocean Biomedical to be delisted from Nasdaq following appeal denial - Investing.com
Ocean Biomedical licenses with Elkurt terminated following breach notice By Investing.com - Investing.com India
Ocean Biomedical Faces License Termination by Elkurt - TipRanks
Ocean Biomedical licenses with Elkurt terminated following breach notice - Investing.com
Ocean Biomedical faces license terminations over breaches - Investing.com
Ocean Biomedical faces license terminations over breaches By Investing.com - Investing.com Nigeria
Ocean Biomedical Faces License Termination Notice - TipRanks
SEC filing of the week: Ocean Biomedical posts $8.42M loss in Q1 - Providence Business News
Sidoti Events, LLC's Virtual June Small-Cap Conference - The Globe and Mail
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value - Voice of Alexandria
Ocean Biomedical, Inc. SEC 10-Q Report - TradingView
Dr. Chirinjeev Kathuria - Smart Business Dealmakers
Ocean Biomedical (NASDAQ: OCEA) Announces $1 Million Falk Award for Malaria Drug Candidate Addressing Evolving Resistance to Artemisinin-Based Therapeutics to Chief Scientist Dr. Jonathan Kurtis - Seeking Alpha
Ocean Biomedical stock plunges to 52-week low of $0.28 - MSN
SEC filing of the week: Ocean Biomedical expands into energy, digital assets; delisted from Nasdaq - Providence Business News
United States shares higher at close of trade; Dow Jones Industrial Average up 1.07% - Investing.com India
Brown spinoff Ocean Biomedical, knocked off the Nasdaq, becomes a 'crypto and energy' company - The Business Journals
Ocean Biomedical expands into energy and crypto sectors - Investing.com Australia
Ocean Biomedical (OCEA) Plunges 50.00% on Diversification Shift - AInvest
why Ocean Biomedical Inc [OCEA] is a Good Choice for Investors After New Price Target of $18.50 - dbtnews.com
Ocean Biomedical expands into energy and crypto sectors By Investing.com - Investing.com South Africa
Ocean Biomedical Inc: Weathering Stock Market Storms with 6.06M Market Cap - investchronicle.com
Ocean Biomedical (OCEA) Expands into Power Infrastructure and Crypto - GuruFocus
Ocean Biomedical (OCEA) Diversifies into Power and Cryptocurrency Sectors | OCEA Stock News - GuruFocus
Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value - The Manila Times
Ocean Biomedical Reveals Dramatic Business Transformation: Biotech Giant Expands into Energy and Digital Assets - Stock Titan
Ocean Biomedical Delays Yearly Report Filing - MSN
Ocean Biomedical stock plunges to 52-week low of $0.04 - Investing.com
Ocean Biomedical stock plunges to 52-week low of $0.04 By Investing.com - Investing.com Canada
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decrease in Short Interest - Defense World
Troubled Brown spinoff Ocean Biomedical racked up more losses in 2024 - The Business Journals
SEC filing of the week: Ocean Biomedical’s loss narrows to $9.4M in 2024 - Providence Business News
How does OCEA's Q3 forecast compare to past quarters? - AInvest
Ocean Biomedical, Inc. SEC 10-K Report - TradingView
Ocean Biomedical stock plunges to 52-week low of $0.05 - Investing.com
Ocean Biomedical stock plunges to 52-week low of $0.05 By Investing.com - Investing.com South Africa
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decline in Short Interest - Defense World
New CEO, several board members to step down from Ocean Biomedical - Providence Business News
Ocean Biomedical secures key patent in China for cancer therapy By Investing.com - Investing.com South Africa
Ocean Biomedical secures key patent in China for cancer therapy - Investing.com
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China - The Manila Times
0.91%
3.06%
자본화:
|
볼륨(24시간):